Vikas Lifecare Posts ₹12,764 Lakh Profit After Restating H1 Results
Verified article - details checked for accuracy.
After restating half‑year results to include a 51% stake in Ebix International Holdings Ltd (UK), Vikas Lifecare posted a profit of ₹12,764.23 Lakh in Q3 2025, with total income of ₹14,165.94 Lakh driven by the Agro segment.
- Restated half‑year profit flipped from a loss to ₹12,764.23 Lakh; basic/diluted EPS rose to 0.69.
- Q3 revenue surged to ₹14,165.94 Lakh, with the Agro segment contributing roughly ₹12,607 Lakh.
- Operating cash flow turned positive at ₹40,109.79 Lakh, boosting net cash to ₹613.64 Lakh.
- Balance sheet remains robust: assets ₹80,523.63 Lakh, equity ₹66,902.96 Lakh, liabilities ₹13,620.69 Lakh.
- Execution risk persists as shareholder and regulatory approvals for related‑party deals and the IGL Genesis transaction are still pending, and tax implications of the Ebix acquisition are under review.
Complete ArticleExclusive Frism Intelligence Report
Frism is a financial information and news discovery platform. We provide factual summaries and data correlations for educational and informational purposes only. Frism does not provide investment advice, buy/sell recommendations, or directional market outlooks. Users should consult a qualified financial advisor before making any investment decisions.